U.S. consumers pay higher prices for weight loss drugs than any other country in the world ... Novo Nordisk, the maker of Ozempic, Rybelsus and Wegovy, said in a statement to CBS News: "It's important ...

Among GLP-1 patients, prescription drug costs drove most of the spending increase ... which are both liraglutide, Rybelsus, an oral version of semaglutide, or Lilly's Trulicity (dulaglutide).

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Among GLP-1 patients, prescription drug costs drove most of the spending increase ... which are both liraglutide, Rybelsus, an oral version of semaglutide, or Lilly's Trulicity (dulaglutide).

Among GLP-1 patients, prescription drug costs drove most of the spending increase ... which are both liraglutide, Rybelsus, an oral version of semaglutide, or Lilly's Trulicity (dulaglutide).